Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)
Italy · Delayed Price · Currency is EUR 50.20
-1.65 (-3.18%)
Nov 19, 2025, 5:35 PM CET
Recordati Industria Chimica e Farmaceutica Employees
As of December 31, 2024, Recordati Industria Chimica e Farmaceutica had 4,583 total employees, including 4,495 full-time and 88 part-time employees. The number of employees increased by 128 or 2.87% compared to the previous year.
Employees
4,583
Change (1Y)
128
Growth (1Y)
2.87%
Revenue / Employee
€574,077
Profits / Employee
€90,875
Market Cap
10.27B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4,583 | 128 | 2.87% |
| Dec 31, 2023 | 4,455 | 86 | 1.97% |
| Dec 31, 2022 | 4,369 | 66 | 1.53% |
| Dec 31, 2021 | 4,303 | -183 | -4.08% |
| Dec 31, 2020 | 4,486 | 163 | 3.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Amplifon | 15,070 |
| GPI S.p.A. | 7,656 |
| Safilo Group | 3,645 |
| DiaSorin | 3,308 |
| Garofalo Health Care | 2,708 |
| EL.En. | 2,080 |
| Svas Biosana | 327 |
| Talea Group | 240 |
Recordati Industria Chimica e Farmaceutica News
- 6 days ago - Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Amarin outlines accelerated path to positive free cash flow in 2026 supported by Recordati partnership and $70M OpEx savings - Seeking Alpha
- 4 months ago - Amarin targets $70M cost savings and accelerates VAZKEPA European expansion through Recordati partnership - Seeking Alpha
- 4 months ago - Italy's Recordati CEO sees rare disease drugs exempt from U.S. tariffs - Reuters
- 4 months ago - Five years after COVID, pharma shares languish in US policy limbo - Reuters
- 5 months ago - Amarin Shares Surge After $175M European Licensing Deal For Heart Drug VAZKEPA - Benzinga
- 5 months ago - Amarin Lands Massive European Commercialization Deal For Heart Drug Vazkepa, Stock Surges - Benzinga
- 5 months ago - Amarin inks licensing deal with Recordati for lead drug Vazkepa - Seeking Alpha